Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hezhe Lu

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|March 30, 2023
Identification of IRAK1BP1 as a candidate prognostic factor in lung adenocarcinomaLei Guo, Weiping Zhou, Ziwei Xu, et al.
Cellular & Molecular Immunology|June 29, 2023
Wip1 inhibits neutrophil extracellular traps to promote abscess formation in mice by directly dephosphorylating Coronin-1aYifang Chen, Chenxu Zhao, Han Guo, et al.
Developmental Cell|December 17, 2013
Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasionHezhe Lu, Jianglan Liu, Shujing Liu, et al.
The EMBO Journal|August 17, 2010
An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transitionClaude C Warzecha, Peng Jiang, Karine Amirikian, et al.
Cell Proliferation|August 1, 2025
PTRF Confers Melanoma-Acquired Drug Resistance Through the Upregulation of EGFRMiao Wang, Ying Cao, Chengcheng Ren, et al.
Developmental Cell|March 25, 2025
Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanomaAicun Li, Zhicheng Gong, Yuhan Long, et al.
Heliyon|May 19, 2023
Distinct genomic features between osteosarcomas firstly metastasing to bone and to lungLu Xie, Zhenyu Cai, Hezhe Lu, et al.
Journal for Immunotherapy of Cancer|May 20, 2021
Dichotomous and stable gamma delta T-cell number and function in healthy individualsLingling Ou, Huaishan Wang, Qin Liu, et al.
Cell Reports|May 24, 2016
Oncogenic BRAF-Mediated Melanoma Cell InvasionHezhe Lu, Shujing Liu, Gao Zhang, et al.
Oncogene|July 25, 2021
Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanomaBeike Wang, Wei Zhang, Gao Zhang, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|March 30, 2023
Identification of IRAK1BP1 as a candidate prognostic factor in lung adenocarcinomaLei Guo, Weiping Zhou, Ziwei Xu, et al.
Cellular & Molecular Immunology|June 29, 2023
Wip1 inhibits neutrophil extracellular traps to promote abscess formation in mice by directly dephosphorylating Coronin-1aYifang Chen, Chenxu Zhao, Han Guo, et al.
Developmental Cell|December 17, 2013
Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasionHezhe Lu, Jianglan Liu, Shujing Liu, et al.
The EMBO Journal|August 17, 2010
An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transitionClaude C Warzecha, Peng Jiang, Karine Amirikian, et al.
Cell Proliferation|August 1, 2025
PTRF Confers Melanoma-Acquired Drug Resistance Through the Upregulation of EGFRMiao Wang, Ying Cao, Chengcheng Ren, et al.
Developmental Cell|March 25, 2025
Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanomaAicun Li, Zhicheng Gong, Yuhan Long, et al.
Heliyon|May 19, 2023
Distinct genomic features between osteosarcomas firstly metastasing to bone and to lungLu Xie, Zhenyu Cai, Hezhe Lu, et al.
Journal for Immunotherapy of Cancer|May 20, 2021
Dichotomous and stable gamma delta T-cell number and function in healthy individualsLingling Ou, Huaishan Wang, Qin Liu, et al.
Cell Reports|May 24, 2016
Oncogenic BRAF-Mediated Melanoma Cell InvasionHezhe Lu, Shujing Liu, Gao Zhang, et al.
Oncogene|July 25, 2021
Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanomaBeike Wang, Wei Zhang, Gao Zhang, et al.
Pageof 3